Buy Fate Therapeutics Stock | FATE Stock Price & Latest News | Public.com
FATE

Fate Therapeutics

$0.00 (0.00%)Today
    View Fate Therapeutics (FATE) stock trends here

    About FATE

    Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products include immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, R...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.23
    -0.45
    -0.68
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.40

    Actual EPS
    Q1 2021

    Stats

    Market Cap$9,32B
    Volume228,78k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$121.16
    1 Year Low$16.75
    Open$96.82
    High$98.97
    Low$92.50

    Buy any stock with any amount of money.

    Download the App
    Download the app